140 related articles for article (PubMed ID: 3293841)
1. In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin.
Dodion P; Sanders C; Georges P; Kenis Y
Cancer Chemother Pharmacol; 1988; 22(1):80-2. PubMed ID: 3293841
[TBL] [Abstract][Full Text] [Related]
2. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.
Schroyens W; Dodion P; Rozencweig M
J Cancer Res Clin Oncol; 1990; 116(4):392-6. PubMed ID: 2202731
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of platinum analogue cytotoxicity by hyperthermia.
Xu MJ; Alberts DS
Cancer Chemother Pharmacol; 1988; 21(3):191-6. PubMed ID: 3282706
[TBL] [Abstract][Full Text] [Related]
4. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
[TBL] [Abstract][Full Text] [Related]
5. Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay.
Schroyens WA; Meeker JB; Dodion P; Stryckmans PA; Rozencweig M
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1309-12. PubMed ID: 3053206
[TBL] [Abstract][Full Text] [Related]
6. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro.
Harstrick A; Casper J; Guba R; Wilke H; Poliwoda H; Schmoll HJ
Cancer; 1989 Mar; 63(6):1079-83. PubMed ID: 2645036
[TBL] [Abstract][Full Text] [Related]
8. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
9. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).
Hrubisko M; Ujházy V
Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083
[TBL] [Abstract][Full Text] [Related]
10. Quantitative ultrastructural effects of cisplatin (Platinol), carboplatin (JM8), and iproplatin (JM9) on neurons of freshwater snail Lymnaea stagnalis.
Müller LJ; Moorer-van Delft CM; Roubos EW; Vermorken JB; Boer HH
Cancer Res; 1992 Feb; 52(4):963-73. PubMed ID: 1737358
[TBL] [Abstract][Full Text] [Related]
11. Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay.
Daidone MG; Silvestrini R; Zaffaroni N; Grignolio E; Landoni F
Invest New Drugs; 1987; 5(3):245-50. PubMed ID: 3312080
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay.
Roed H; Vindeløv LL; Christensen IJ; Spang-Thomsen M; Hansen HH
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):247-53. PubMed ID: 2833402
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
[TBL] [Abstract][Full Text] [Related]
14. The relative effectiveness of analogues of cisplatin in the experimental chemotherapy of human non-small-cell lung cancer and neuroblastoma grown as multicellular spheroids.
Russell J; Adam J; Wheldon TE; Kaye SB
Cancer Chemother Pharmacol; 1989; 23(2):111-4. PubMed ID: 2535968
[TBL] [Abstract][Full Text] [Related]
15. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Schadendorf D; Worm M; Algermissen B; Kohlmus CM; Czarnetzki BM
Cancer; 1994 Jan; 73(1):103-8. PubMed ID: 7506115
[TBL] [Abstract][Full Text] [Related]
18. In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin.
Mellish KJ; Kelland LR; Harrap KR
Br J Cancer; 1993 Aug; 68(2):240-50. PubMed ID: 8347478
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of drug sensitivity by successive colony-forming assay].
Azuma A; Hino M; Hirosawa A; Shimabukuro Z; Aoyama A; Ootsuka M; Matsusaka M; Niitani H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):815-20. PubMed ID: 3032106
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
Twentyman PR; Wright KA; Mistry P; Kelland LR; Murrer BA
Cancer Res; 1992 Oct; 52(20):5674-80. PubMed ID: 1327513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
